Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

OEF Measured with Diffuse Optical Spectroscopies As a Biomarker of Silent Stroke in Pediatric Sickle Cell Anemia

Rowan Brothers, Michael Arrington, Kristin Wubbena, Ayesha Quadri, Mariam Akbar, Katherine Turrentine, Eswar Damaraju, Richard Jones, Jack Knight-Scott, Bryan Philbrook, Clark Brown, Beatrice E Gee, Kirshma Khemani, Seung Yup Lee, Adam Goldman-Yassen, Erin Buckley

Blood (2024) 144 (Supplement 1): 3885.

https://doi.org/10.1182/blood-2024-199747

Published: 2024

Journal Articles

Feasibility of Using the American Time Use Survey to Study the Impact of Sickle Cell Disease and Hematopoietic Cell Transplant on the Daily Lives of Patients and Their Caregivers: A Stellar Study

Kirshma Khemani, Staci D. Arnold, Nitya Bakshi, Diana Ross, Crystal Smith, Anirban Basu, Elizabeth Stenger, Lakshmanan Krishnamurti

Blood (2022) 140 (Supplement 1): 13043–13044.

https://doi.org/10.1182/blood-2022-170685

Published: 2022

Journal Articles

Impact of Arginine Therapy on Clinical Outcomes, Mitochondrial Function and Oxidative Stress in Children with Sickle Cell Disease Hospitalized with Vasoocclusive Pain Episodes: A Randomized Controlled Trial

Claudia R. Morris, Nitya Bakshi, Deborah Leake, Scott Gillespie, Lou Ann Scism Brown, Frank Harris, Kirshma Khemani, Alexus Locke, Christopher A Rees, Mark A Griffiths, Loretta Reyes, Polly Kumari, Sruti Shiva, Carlton D. Dampier

Blood (2022) 140 (Supplement 1): 16–18.

https://doi.org/10.1182/blood-2022-156577

Published: 2022

Journal Articles

Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR)

Anirudh Veludhandi, Tami D John, Nitya Bakshi, Staci D. Arnold, Monica Bhatia, Peter A. Lane, Lillian Meacham, Kirshma Khemani, Sonali Chaudhury, Festus Olusola Olowoselu, Kimberly A. Kasow, Matthew Hsieh, Allistair Abraham, Gregory M.T. Guilcher, Lakshmanan Krishnamurti

Blood (2021) 138 (Supplement 1): 3030.

https://doi.org/10.1182/blood-2021-152383

Published: 2021

Journal Articles

Safety of Intravenous Arginine Therapy in Children with Sickle Cell Disease Hospitalized for Vaso-Occlusive Pain: A Randomized Placebo-Controlled Trial in Progress

Claudia R. Morris, MD, Janet Figueroa, MPH, Amanda Watt, Kirshma Khemani, MD, Polly Kumari, MBBS, Morgan Barnett, MPH, Nitya Bakshi, MBBS, MS, Peter A. Lane, MD, Carlton Dampier, MD

Blood (2019) 134 (Supplement_1): 995.

https://doi.org/10.1182/blood-2019-122983

Published: 2019

Journal Articles

Vaccination Adherence in Pediatric Patients Post-Hematopoietic Stem Cell Transplant

Kirshma Khemani, MD, Molly K Steele, Nitya Bakshi, MBBS, MS, Lakshmanan Krishnamurti, MD, Inci Yildirim, MD PhD MSc FAAP

Blood (2018) 132 (Supplement 1): 3406.

https://doi.org/10.1182/blood-2018-99-119283

Published: 2018

Journal Articles

Use of an Emergency Department-Based Intranasal Fentanyl Protocol for Vaso-Occlusive Episodes in Sickle Cell Disease: The Unanticipated Consequences

Kirshma Khemani, MD, Lankala Mahati Reddy, MD, Shabnam Jain, MD M.P.H, Amanda Mallino, April Zmitrovich, MSW, MPH, Bolanle Akinsola, MD, Lakshmanan Krishnamurti, MD, Claudia R. Morris, MD

Blood (2017) 130 (Supplement 1): 2264.

https://doi.org/10.1182/blood.V130.Suppl_1.2264.2264

Published: 2017

Journal Articles

Increased Proportion of Sickle Cell Disease Patients Develop Cardiovascular Disease Risk Factors Following Successful Hematopoietic Cell Transplantation

Elizabeth Stenger, MD, Kirshma Khemani, MD, Diana Ross, MSN, RN, Lillian Meacham, MD, Courtney McCracken, PhD, Ann Haight, MD, Lakshmanan Krishnamurti, MD

Blood (2017) 130 (Supplement 1): 1999.

https://doi.org/10.1182/blood.V130.Suppl_1.1999.1999

Published: 2017

Journal Articles

Development, Implementation, and Testing of a Web Based Decision Aid for Facilitating Shared Decision Making for Disease Modifying Therapies for Sickle Cell Disease

Lakshmanan Krishnamurti, MD, Diana Ross, MSN, RN, Nitya Bakshi, MBBS, MS, Kirshma Khemani, MD, Cynthia Sinha, PhD, George Loewenstein, PhD

Blood (2016) 128 (22): 5919.

https://doi.org/10.1182/blood.V128.22.5919.5919

Published: 2016

Journal Articles

What Are the Expectations of Patients in Decision Making Process for Disease Modifying Therapies for Sickle Cell Disease: Do They Care about Shared Decision Making?

Diana Ross, MSN, RN, Nitya Bakshi, MBBS, MS, Kirshma Khemani, MD, Cynthia Sinha, PhD, George Loewenstein, PhD, Lakshmanan Krishnamurti, MD

Blood (2016) 128 (22): 5968.

https://doi.org/10.1182/blood.V128.22.5968.5968

Published: 2016

Journal Articles

Experiences and Decision Making for Bone Marrow Transplant in Sickle Cell Disease: Patients and Caregivers Perspective

Kirshma Khemani, MD, Diana Ross, MSN, RN, Ann Haight, MD, Cynthia Sinha, PhD, Nitya Bakshi, MBBS, MS, Lakshmanan Krishnamurti, MD

Blood (2016) 128 (22): 2393.

https://doi.org/10.1182/blood.V128.22.2393.2393

Published: 2016

Journal Articles

Shared Decision Making or Physician Advocate for a Particular Treatment Option: A Spectrum of Approaches to Decision Making about Disease Modifying Therapies in Sickle Cell Disease

Nitya Bakshi, MBBS, MS, Cynthia Sinha, PhD, Diana Ross, MSN, RN, Kirshma Khemani, MD, George Loewenstein, PhD, Lakshmanan Krishnamurti, MD

Blood (2016) 128 (22): 4757.

https://doi.org/10.1182/blood.V128.22.4757.4757

Published: 2016

Journal Articles

Red Blood Cell Exchange Transfusion, An Underutilized Effective and Reliable Therapeutic Modality in Sickle Cell Disease, Reduces Number of Admissions and Length of Hospital Stay

Aref Agheli, MD, Kirshma Khemani, MS, Madhumati Kalavar, MD, William Steier, MD, Zili He, MD

Blood (2008) 112 (11): 4822.

https://doi.org/10.1182/blood.V112.11.4822.4822

Published: 2008

Journal Articles

Relation of Non-Restrictive Blood Products Transfusion to Poorer Clinical Outcome and Higher Mortality in Patients with Septic Shock

Aref Agheli, MD, Arsh Singh, MD, Kirshma Khemani, MS, Madhumati Kalavar, MD, Zili He, MD, William Steier, MD

Blood (2008) 112 (11): 4070.

https://doi.org/10.1182/blood.V112.11.4070.4070

Published: 2008

NARROW

OEF Measured with Diffuse Optical Spectroscopies As a Biomarker of Silent Stroke in Pediatric Sickle Cell Anemia

Feasibility of Using the American Time Use Survey to Study the Impact of Sickle Cell Disease and Hematopoietic Cell Transplant on the Daily Lives of Patients and Their Caregivers: A Stellar Study

Impact of Arginine Therapy on Clinical Outcomes, Mitochondrial Function and Oxidative Stress in Children with Sickle Cell Disease Hospitalized with Vasoocclusive Pain Episodes: A Randomized Controlled Trial

Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR)

Safety of Intravenous Arginine Therapy in Children with Sickle Cell Disease Hospitalized for Vaso-Occlusive Pain: A Randomized Placebo-Controlled Trial in Progress

Vaccination Adherence in Pediatric Patients Post-Hematopoietic Stem Cell Transplant

Use of an Emergency Department-Based Intranasal Fentanyl Protocol for Vaso-Occlusive Episodes in Sickle Cell Disease: The Unanticipated Consequences

Increased Proportion of Sickle Cell Disease Patients Develop Cardiovascular Disease Risk Factors Following Successful Hematopoietic Cell Transplantation

Development, Implementation, and Testing of a Web Based Decision Aid for Facilitating Shared Decision Making for Disease Modifying Therapies for Sickle Cell Disease

What Are the Expectations of Patients in Decision Making Process for Disease Modifying Therapies for Sickle Cell Disease: Do They Care about Shared Decision Making?

Experiences and Decision Making for Bone Marrow Transplant in Sickle Cell Disease: Patients and Caregivers Perspective

Shared Decision Making or Physician Advocate for a Particular Treatment Option: A Spectrum of Approaches to Decision Making about Disease Modifying Therapies in Sickle Cell Disease

Red Blood Cell Exchange Transfusion, An Underutilized Effective and Reliable Therapeutic Modality in Sickle Cell Disease, Reduces Number of Admissions and Length of Hospital Stay

Relation of Non-Restrictive Blood Products Transfusion to Poorer Clinical Outcome and Higher Mortality in Patients with Septic Shock

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only